Innovative products for
the common good
The last few years have seen a lot of change in the pharmaceutical industry. Important pharmaceutical raw materials for the production of medicines are manufactured almost exclusively in the Far East. The reason for this are the partly drastic measures taken by politicians in Europe, but especially in Germany, to contain costs in public healthcare.
Supply of medicinal products
As a result, more and more pharmaceutical companies have outsourced their production to Asia. Unfortunately, the American and European regulatory authorities repeatedly find that many raw materials are not produced in compliance with GMP and sometimes contain impurities.
This ultimately leads to a shortage of drugs, some of which are urgently needed, for example antibiotics.
Synverdis has committed itself to becoming part of the policy's drive to reestablish the production of active pharmaceutical substances in Germany and Europe.